Luxiang Liu

Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study

H. Xiang, Yan Yan, Wenhong Zhang, 2021, Clinical Gastroenterology and Hepatology.

Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

H. Xiang, Xianghui Qi, Jing-wen Ai, 2022, Hepatology International.

Screening of ferroptosis-related genes in sepsis-induced liver failure and analysis of immune correlation

Qingli Chen, Luxiang Liu, Shuangling Ni, 2022, PeerJ.

Prevalence and mechanisms of carbapenem resistance  among  Klebsiella aerogenes  in a tertiary hospital in China

Dongdong Zhao, J. Quan, Yunsong Yu, 2020 .

Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective study

H. Xiang, Xianghui Qi, Chuan Liu, 2022, Journal of medical virology.